# 119-s-1637: MVP Act

119-s-1637, MVP Act, is a 119th Congress bill sponsored by Rep. Mullin, Markwayne [R-OK-2] (R-OK); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-s-1637
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-1637
- Congress: 119
- Title: MVP Act
- Status: introduced
- Introduced: 2025-05-07
- Sponsor: Rep. Mullin, Markwayne [R-OK-2] (R-OK)
- Cosponsors: 2
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Value-based purchasing arrangements** for drugs. This bill would let Medicaid use different "best price" points when drug payments are tied to patient outcomes and it would change how manufacturers report prices and how Medicare counts some outcome-based payments.

## Cosponsors (2)

- Sen. Hassan, Margaret Wood [D-NH] (D-NH), 2025-05-07T00:00:00.000Z
- Sen. Scott, Tim [R-SC] (R-SC), 2025-05-07T00:00:00.000Z

## Provisions PRIA read

- Guidance for states on inpatient drug payments: benefit, medium. If enacted, the HHS Secretary would give states guidance within 180 days on value-based deals for drugs used with inpatient hospital care when the drug is paid for directly. The guidance must address how multiple States can enter agreements and transfer funds. That would let a patient treated outsi…
- GAO study on value-based drug purchasing: benefit, low. If enacted, the Comptroller General would study how value-based drug deals affect access, outcomes, and overall costs. The study would analyze effects on rare gene therapies, disparities, interactions with Medicaid rebates, the 340B and Medicare Part B programs, pricing structures, and possible lon…
- New drug pricing and rebate rules: mixed, high. If enacted, this would change how drug makers report prices to Medicaid and Medicare for value-based deals. Outcome-triggered refunds, rebates, reimbursements, or withheld payments would count toward the Average Manufacturer Price during the rebate period. For installment payment deals, the full pr…
- Allow states to get outcome-based drug payments: mixed, medium. If enacted, the bill would add an exception to the federal Anti-Kickback Statute. This would let a drug maker—or a third party on its behalf—pay a State under a value-based purchasing deal when a patient fails to meet agreed outcomes after getting a covered outpatient drug. The rule would apply to…

## Related bills

- 119-s-2120: Older Americans Act Reauthorization Act of 2025
- 119-s-1532: A bill to amend the Internal Revenue Code of 1986 to modify the railroad track maintenance credit.
- 119-s-2121: SUPPORT for Patients and Communities Reauthorization Act of 2025
- 119-s-339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-sres-585: A resolution honoring the life, achievements, and legacy of Ben Nighthorse Campbell.
- 119-sres-255: A resolution honoring the life, achievements, and legacy of former United States Senator Christopher "Kit" Bond of Missouri.

## Sources
- [119-s-1637 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/1637)

## Related
- [119-s-2120: Older Americans Act Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-2120)
- [119-s-1532: A bill to amend the Internal Revenue Code of 1986 to modify the railroad track…](https://policyrisk.com/legislation/119-s-1532)
- [119-s-2121: SUPPORT for Patients and Communities Reauthorization Act of 2025](https://policyrisk.com/legislation/119-s-2121)
- [119-s-339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-s-339)
- [119-sres-585: A resolution honoring the life, achievements, and legacy of Ben Nighthorse Camp…](https://policyrisk.com/legislation/119-sres-585)
- [119-sres-255: A resolution honoring the life, achievements, and legacy of former United State…](https://policyrisk.com/legislation/119-sres-255)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-1637 (as of 2026-04-21).